Showing 588 Results
AMCP Outlines Changes to Format for Formulary Submissions
The Academy of Managed Care Pharmacy today released its updated Format for Formulary Submissions, Version 4.0, which enables health care decision-makers and biopharmaceutical companies to…
Bundled Payments: Opportunities and Challenges
A study by NPC Director of Research Michael Ciarametaro and Chief Science Officer Dr. Robert W. Dubois published on the Health Affairs blog lays out core principles that are critical to steering…
Using Evidence Appropriately to Inform Value Assessments
The National Pharmaceutical Council recently unveiled “Guiding Practices for Patient-Centered Value Assessment,” which offer comprehensive considerations for the development and application of…
Accounting for Benefits and Costs—Patient Preferences, Time Horizons and User Considerations For Value Assessments
We recognize there is a tension between balancing benefits and costs when it comes to determining or assessing the value of a health care treatment. But focusing too much or too little on either, or…
NQF’s Annual Conference Drives Conversation Around Quality Measures, Value-Based Care
At the National Quality Forum’s 2016 Annual Conference, which the National Pharmaceutical Council is cosponsoring, health care stakeholders will speak about quality measure development, patient…
Methodology Matters in Value Assessments
When it comes to conducting research, synthesizing evidence or assessing value, the methods that are used truly matter. Poor methods lead to poor results, which in turn lead to poor health decision…
Engaging Stakeholders Throughout the Value Assessment Process
Last week, the National Pharmaceutical Council unveiled “Guiding Practices for Patient-Centered Value Assessment,” which offer comprehensive considerations for the development and application of…
Guiding Practices: Looking at Value Assessment Through a Broader, Patient-Focused Lens
There are many aspects to the U.S. health care system, as well as many different stakeholder viewpoints on how to address current challenges as our system shifts from one driven by the volume of…
Going To AMCP? Be Sure To Check Out NPC’s Presentations Exhibit Booth
NPC will present and exhibit at the Academy of Managed Care Pharmacy’s (AMCP) Managed Care & Specialty Pharmacy Annual Meeting, which takes place through April 19-22 at the Moscone West…
NPC’s Dr. Graff to Discuss Incentives & Policy Options to Improve Real-World Evidence
NPC Vice President of Comparative Effectiveness Research Dr.
NPC’s Westrich to Answer: Have ACO Medication Capabilities Improved?
NPC Vice President of Health Services Research Kimberly Westrich will discuss accountable care organizations’ (ACOs) current abilities in utilizing medications to achieve the best patient health…
NPC’s Dr. Dubois Answers: Are ACOs Ready to Manage Medications?
NPC Chief Science Officer Robert Dubois, MD, PhD, will present recommendations on how to optimally use medications to achieve success in value-based health during a panel at the Value-Based Payment…
New Study Puts Previous 5 Years of NPC Annual CER Survey Into Perspective
For the last five years, we’ve had our fingers on the pulse of what health care stakeholders are thinking about comparative effectiveness research and its potential impact on health care decision…
#TBT: Moonshot to Cure Cancer & the Importance of Individual Treatment Effects
As part of our Throwback Thursday blog series, we’re taking a look at an issue currently in the news and tagging it with previous research, videos or commentaries in a relevant way. As the saying…
Five Questions About New Health Policy Fellowship Answered
Are you looking for a post-doctoral fellowship in health policy? The National Pharmaceutical Council (NPC) and the University of Southern California’s (USC) Schaeffer Center for Health Policy and…
ASCO’s Clinical Pathways Recommendations and Remaining Challenges
The American Society of Clinical Oncology (ASCO) today released its “policy statement on clinical pathways in oncology,” which acknowledges the challenges in developing these pathways and offers…
Key Considerations for Cost Effectiveness Thresholds
In his latest column in the Journal of Comparative Effectiveness Research (JCER), National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, discusses what broad use of cost…
#TBT: Five Most Popular NPC Blog Posts of 2015
As part of our Throwback Thursday blog series, we’re taking a look at a topic that’s currently in the news and tagging it with previous research, videos or commentaries in a relevant way. As the…
FDA/CMS Summit Offers Opportunity to Focus on Value
From the 21st Century Cures Act to negotiations about reauthorizing the Prescription Drug User Fee Act (PDUFA), much of this year has been focused on a range of health care issues—including how to…
Standards and Subgroups: Why it’s Important to Account for Differences Across Patient Groups When Developing Quality Measures
Sue Peschin, president and CEO of the Alliance for Aging Research, noted during a conversation with the National Pharmaceutical Council (NPC), while “it’s always been important for clinicians to be…